Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 21
2008 43
2009 60
2010 66
2011 74
2012 89
2013 72
2014 68
2015 71
2016 62
2017 53
2018 81
2019 69
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

730 results
Results by year
Filters applied: . Clear all
Page 1
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD. Sterne JA, et al. Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090. Health Technol Assess. 2017. PMID: 28279251 Free PMC article. Review.
SETTING: Hospital (VTE primary prevention and acute treatment) and primary care/anticoagulation clinics (AF and VTE secondary prevention). ...RESULTS: Apixaban (Eliquis(®), Bristol-Myers Squibb, USA; Pfizer, USA) [5 mg bd (twice daily)] was ranked as among th …
SETTING: Hospital (VTE primary prevention and acute treatment) and primary care/anticoagulation clinics (AF and VTE secondary prevent …
Prevention of venous thromboembolism in gynecologic oncology surgery.
Barber EL, Clarke-Pearson DL. Barber EL, et al. Gynecol Oncol. 2017 Feb;144(2):420-427. doi: 10.1016/j.ygyno.2016.11.036. Epub 2016 Nov 25. Gynecol Oncol. 2017. PMID: 27890280 Free PMC article. Review.
Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge …
Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative …
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology. Lyman GH, et al. J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605844 Free PMC article.
RECOMMENDATIONS: Most hospitalized patients with active cancer require thromboprophylaxis throughout hospitalization. Routine thromboprophylaxis is not recommended for patients with cancer in the outpatient setting. ...
RECOMMENDATIONS: Most hospitalized patients with active cancer require thromboprophylaxis throughout hospitalization. Routine …
Cancer and Venous Thromboembolic Disease: A Review.
Donnellan E, Khorana AA. Donnellan E, et al. Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7. Oncologist. 2017. PMID: 28174293 Free PMC article. Review.
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboprophylaxis may be used in carefully selected high-risk ambulatory patients. ...
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboproph …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A. Farge D, et al. Lancet Oncol. 2016 Oct;17(10):e452-e466. doi: 10.1016/S1470-2045(16)30369-2. Lancet Oncol. 2016. PMID: 27733271 Review.
These guidelines aim to address in-hospital and outpatient cancer-associated VTE in specific subgroups of patients with cancer....
These guidelines aim to address in-hospital and outpatient cancer-associated VTE in specific subgroups of patients with cancer....
Deep venous thrombosis and venous thromboembolism prophylaxis.
Buesing KL, Mullapudi B, Flowers KA. Buesing KL, et al. Surg Clin North Am. 2015 Apr;95(2):285-300. doi: 10.1016/j.suc.2014.11.005. Surg Clin North Am. 2015. PMID: 25814107 Review.
Development of VTE remains a high risk in hospitalized surgical patients, leading to complications in up to 30%. The stratification of patient risk factors and subsequent utilization of a validated prophylaxis and treatment regimen is, therefore, of utmost importance. ...
Development of VTE remains a high risk in hospitalized surgical patients, leading to complications in up to 30%. The stratification o …
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
Chi G, Goldhaber SZ, Kittelson JM, Turpie AGG, Hernandez AF, Hull RD, Gold A, Curnutte JT, Cohen AT, Harrington RA, Gibson CM. Chi G, et al. J Thromb Haemost. 2017 Oct;15(10):1913-1922. doi: 10.1111/jth.13783. Epub 2017 Sep 4. J Thromb Haemost. 2017. PMID: 28762617 Free article.
SUMMARY: Background Among acutely ill hospitalized medical patients, extended-duration thromboprophylaxis reduces the risk of venous thromboembolism (VTE), but some pharmacologic strategies have been associated with greater risks of major bleeding, thereby offsetting the n …
SUMMARY: Background Among acutely ill hospitalized medical patients, extended-duration thromboprophylaxis reduces the risk of venous …
Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.
Nyquist P, Bautista C, Jichici D, Burns J, Chhangani S, DeFilippis M, Goldenberg FD, Kim K, Liu-DeRyke X, Mack W, Meyer K. Nyquist P, et al. Neurocrit Care. 2016 Feb;24(1):47-60. doi: 10.1007/s12028-015-0221-y. Neurocrit Care. 2016. PMID: 26646118 Review.
730 results
Jump to page
Feedback